-
Product Insights
NewCaspase 9 – Drugs In Development, 2024
The Caspase 9 pipeline drugs market research report outlays comprehensive information on the Caspase 9 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Dermatology, and Infectious Disease which include indications of Oncology, Prostate Cancer, Psoriasis, Rheumatoid Arthritis, Actinic (Solar) Keratosis, Atopic Dermatitis (Atopic Eczema), and Unspecified Influenza Virus Infections. It also reviews key players involved...
-
Product Insights
NewTumor Necrosis Factor Receptor Superfamily Member 1A – Drugs In Development, 2024
The Tumor Necrosis Factor Receptor Superfamily Member 1A pipeline drugs market research report outlays comprehensive information on the Tumor Necrosis Factor Receptor Superfamily Member 1A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Dermatology, and Central Nervous System which include indications of Melanoma, Solid Tumor, Rheumatoid Arthritis, Inflammation, Atopic Dermatitis (Atopic Eczema), Actinic (Solar) Keratosis,...
-
Product Insights
NewToll Like Receptor 7 – Drugs In Development, 2024
The Toll Like Receptor 7 pipeline drugs market research report outlays comprehensive information on the Toll Like Receptor 7 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, Immunology, and Dermatology which include indications of Solid Tumor, Melanoma, Human Immunodeficiency Virus (HIV) Infections (AIDS), Hepatitis B, Systemic Lupus Erythematosus, Inflammation, Dermatological Disorders, and Actinic (Solar)...
-
Product Insights
NewThymidylate Synthase – Drugs In Development, 2024
The Thymidylate Synthase pipeline drugs market research report outlays comprehensive information on the Thymidylate Synthase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, and Dermatology which include indications of Pancreatic Cancer, Gastric Cancer, Cryptococcal Meningitis, Bacterial Infections, Actinic (Solar) Keratosis, and Hypertrophic Scars. It also reviews key players involved in Thymidylate Synthase targeted therapeutics...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afamelanotide Acetate in Vitiligo
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamelanotide Acetate in Vitiligo report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamelanotide Acetate in Vitiligo Drug Details: Afamelanotide (Scenesse) is an analog...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bimiralisib in Actinic (Solar) Keratosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bimiralisib in Actinic (Solar) Keratosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bimiralisib in Actinic (Solar) Keratosis Drug Details: Bimiralisib (PQR-309) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST-002 in Cushing’s Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST-002 in Cushing's Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST-002 in Cushing's Syndrome Drug Details: ST-002 (fluasterone) is under development...
-
Product Insights
Likelihood of Approval Analysis for Actinic (Solar) Keratosis
Overview How likely is it that the drugs in Actinic (Solar) Keratosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Actinic (Solar) Keratosis Overview An actinic keratosis, also known as a...
-
Product Insights
NewActinic (Solar) Keratosis – Drugs In Development, 2024
Empower your strategies with our Actinic (Solar) Keratosis – Drugs In Development, 2024 report and make more profitable business decisions. An actinic keratosis, also known as a solar keratosis, is a scaly or crusty growth (lesion). It most often appears on the bald scalp, face, ears, lips, backs of the hands and forearms, shoulders, neck, or any other areas of the body frequently exposed to the sun. The signs and symptoms of an actinic keratosis include a hard, wart-like surface, patch...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MWPC-005 in Basal Cell Carcinoma (Basal Cell Epithelioma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MWPC-005 in Basal Cell Carcinoma (Basal Cell Epithelioma) Drug Details: MWPC-005 is under development for...